Pancreas transplantation.
Journal
Current opinion in organ transplantation
ISSN: 1531-7013
Titre abrégé: Curr Opin Organ Transplant
Pays: United States
ID NLM: 9717388
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
pubmed:
9
6
2021
medline:
17
7
2021
entrez:
8
6
2021
Statut:
ppublish
Résumé
To define recent changes and future directions in the practice of pancreas transplantation (PT). Two major events have occurred in the past 18 months: COVID-19 pandemic, and the first world consensus conference on PT. Several innovative studies were published after the consensus conference. During COVID-19 pandemic PT activity decreased. COVID-19 in transplant recipients increases mortality rates, but data from kidney transplantation show that mortality might be higher in waitlisted patients.The world consensus conference provided 49 jury deliberations on the impact of PT on management of diabetic patients and 110 practice recommendations.Recent evidence demonstrates that PT alone is safe and effective, that results of simultaneous pancreas and kidney (SPK) remain excellent despite older recipient age and higher prevalence of type 2 diabetes, that use of hepatitis C virus (HCV)-positive donors into HCV-negative recipients is associated with good outcomes, and that use of sirolimus as primary immunosuppressant and costimulation blockade does not improve results of SPK. COVID-19 pandemic and the first world consensus conference on PT were major events. Although COVID-19 pandemic should not reduce PT activity in the future, a major positive impact on both volume and outcomes of PT is awaited from the proceedings of the world consensus conference.
Identifiants
pubmed: 34101665
doi: 10.1097/MOT.0000000000000900
pii: 00075200-202108000-00006
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
381-389Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Bantig FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med 1922; 7:251.
Nathan DM, Genuth S, Lachin J, et al. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–986.
Boscari F, Avogaro A. Current treatment options and challenges in patients with Type 1 diabetes: pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord 2021; 22:217–240.
Kelly WD, Lillehei RC, Merkel FK, et al. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967; 61:827–837.
Smith GC, Trauer T, Kerr PG, et al. Prospective Quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis 2010; 55:698–707.
Isla P, Moncho J, Torras A, et al. Quality of life in simultaneous pancreas-kidney transplant recipients. Clin Transplant 2009; 23:600–605.
Mohan P, Safi K, Little DM, et al. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 2003; 90:1137–1141.
Tibell A, Solders G, Larsson M, et al. Superior survival after simultaneous pancreas and kidney transplantation compared with transplantation of a kidney alone in diabetic recipients followed for 8 years. Transpantl Proc 1997; 29:668.
Lombardo C, Perrone VG, Amorese G, et al. Update on pancreatic transplantation on the management of diabetes. Minerva Med 2017; 108:405–418.
Boggi U, Signori S, Vistoli F, et al. Laparoscopic robot-assisted pancreas transplantation: first world experience. Transplantation 2012; 93:201–206.
Spaggiari M, Tulla KA, Okoye O, et al. The utility of robotic assisted pancreas transplants - a single center retrospective study. Transpl Int 2019; 32:1173–1181.
Danziger-Isakov L, Blumberg EA, et al. Impact of COVID-19 in solid organ transplant recipients. Am J Transplant 2021; 21:925–937.
Kates OS, Haydel BM, Florman SS, et al. UW COVID-19 SOT Study Team. COVID-19 in solid organ transplant: A multi-center cohort study. Clin Infect Dis 2020; ciaa1097doi: 10.1093/cid/ciaa1097. [Epub ahead of print].
doi: 10.1093/cid/ciaa1097.
Hadi YB, Naqvi SF, Kupec JT, et al. Outcomes of coronavirus infectious disease -19 (COVID-19) in solid organ transplant recipients: a propensity matched analysis of a large research network. Transplantation 2021; 105:1365–1371.
Ravanan R, Callaghan CJ, Mumford L, et al. SARS-CoV-2 infection and early mortality of wait-listed and solid organ transplant recipients in England: a national cohort study. Am J Transplant 2020; 20:3008–3018.
Craig-Schapiro R, Salinas T, Lubetzky M, et al. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. Am J Transplant 2021; 21:1576–1585.
Cholankeril G, Podboy A, Alshuwaykh OS, et al. Early impact of COVID-19 on solid organ transplantation in the United States. Transplantation 2020; 104:2221–2224.
World Pancreas Transplant Covid-19 Collaborative Group. Impact of SARS-CoV-2 on pancreas transplant activity: survey of international surgeons. Br J Surg 2021; 108:e109–e110. doi: 10.1093/bjs/znaa105.
doi: 10.1093/bjs/znaa105
Barros N, Sharfuddin AA, Powelson J, et al. Rabbit antithymocyte globulin administration to treat rejection in simultaneous pancreas and kidney transplant recipients with recent COVID-19 infection. Clin Transplant 2021; 35:e14149.
Babel N, Anft M, Blazquez-Navarro A, et al. Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient. Am J Transplant 2020; 20:3210–3215.
Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, et al. Spanish Group for the Study of COVID-19 in Transplant Recipients. COVID-19 in transplant recipients: The Spanish experience. Am J Transplant 2021; 21:1825–1837.
Dube GK, Husain SA, McCune KR, et al. COVID-19 in pancreas transplant recipients. Transpl Infect Dis 2020; 22:e13359.
Mamode N, Ahmed Z, Jones G, et al. Mortality rates in transplant recipients and transplantation candidates in a high-prevalence COVID-19 environment. Transplantation 2021; 105:212–215.
Vistoli F, Furian L, Maggiore U, et al. Italian National Kidney Transplantation Network; the Joint Committee of the Italian Society of Organ Transplantation and the Italian Society of Nephrology. COVID-19 and kidney transplantation: an Italian survey and consensus. J Nephrol 2020; 33:667–680.
Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant 2020; 20:1800–1808.
Cravedi P, Suraj SM, Azzi Y, et al. COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium. Am J Transplant 2020; 20:3140–3148.
Khairallah P, Aggarwal N, Awan AA, et al. The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic. Transpl Int 2021; 34:612–621.
Lesurtel M, Perrier A, Bossuyt PM, et al. An independent jury-based consensus conference model for the development of recommendations in medico-surgical practice. Surgery 2014; 155:390–397.
Brouwers MC, Kho ME, Browman GP, et al. AGREE Next Steps Consortium. The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. J Clin Epidemiol 2012; 65:526–534.
Scottish Intercollegiate Guidelines Network. SIGN 50 A guideline developer's handbook. Edinburgh 2011 ISBN 978 1 905813 25 4. Available at https://www.sign.ac.uk/sign50 .
Guyatt GH, Oxman AD, Vist GE, et al. for the GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–926.
Dalkey NC, Helmer O. An experimental application of the Delphi method to the use of experts. Manag Sci 1963; 9:458–467.
Boggi U, Baronti W, Amorese G, et al. Treating type 1 diabetes by pancreas transplant alone: a cohort study on actual long-term (10 years) efficacy and safety. Transplantation. 2021. doi: 10.1097/TP.0000000000003627. [Epub ahead of print]
Ruiz S, Amor AJ, Pané A, et al. Cardiovascular risk factors and cardiovascular disease in patients with type 1 diabetes and end-stage renal disease candidates for kidney-pancreas transplantation: Trends from 1999 to 2017. Diabetes Res Clin Pract 2020; 163:108135doi: 10.1016/j.diabres.2020.108135.
doi: 10.1016/j.diabres.2020.108135
Pham PH, Stalter LN, Martinez EJ, et al. Large single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes. Am J Transplant 2020; doi: 10.1111/ajt.16462. [Epub ahead of print].
doi: 10.1111/ajt.16462.
Montagud-Marrahi E, Molina-Andújar A, Pané A, et al. Outcomes of pancreas transplantation in older diabetic patients. BMJ Open Diabetes Res Care 2020; 8:e000916.
Thakkar RG, Kanwar A, Singh A, et al. Preemptive appendicectomy at the time of pancreas transplantation: is it necessary? Exp Clin Transplant 2019; 17:792–795.
Goussous N, St Michel DP, Mcdade H, et al. Is Prophylactic drainage after pancreas transplant associated with reduced reoperation rate? Exp Clin Transplant 2021; 19:64–71.
Lonze BE, Baptiste G, Ali NM, et al. Pancreas transplantation from hepatitis C viremic donors to uninfected recipients. Am J Transplant 2021; 21:1931–1936.
Cantarovich D, Kervella D, Karam G, et al. Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial. Am J Transplant 2020; 20:1679–1690.
Stock PG, Mannon RB, Armstrong B, et al. Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: results of a prospective, randomized clinical trial. Am J Transplant 2020; 20:1668–1678.
Rickels MR, Stock PG, de Koning EJP, et al. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop. Transpl Int 2018; 31:343–352.